SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Walid T. Khaled, Pentao Liu, Cancer mouse models: Past, present and future, Seminars in Cell & Developmental Biology, 2014, 27, 54

    CrossRef

  2. 2
    R. Torres, M. C. Martin, A. Garcia, Juan C. Cigudosa, J. C. Ramirez, S. Rodriguez-Perales, Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system, Nature Communications, 2014, 5,

    CrossRef

  3. 3
    J. Abi-Ghanem, J. Chusainow, M. Karimova, C. Spiegel, H. Hofmann-Sieber, J. Hauber, F. Buchholz, M. T. Pisabarro, Engineering of a target site-specific recombinase by a combined evolution- and structure-guided approach, Nucleic Acids Research, 2013, 41, 4, 2394

    CrossRef

  4. 4
    Nina Cabezas-Wallscheid, Victoria Eichwald, Jos de Graaf, Martin Löwer, Hans-Anton Lehr, Andreas Kreft, Leonid Eshkind, Andreas Hildebrandt, Yasmin Abassi, Rosario Heck, Anna Katharina Dehof, Svetlana Ohngemach, Rolf Sprengel, Simone Wörtge, Steffen Schmitt, Johannes Lotz, Claudius Meyer, Thomas Kindler, Dong-Er Zhang, Bernd Kaina, John C. Castle, Andreas Trumpp, Ugur Sahin, Ernesto Bockamp, Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model, EMBO Molecular Medicine, 2013, 5, 12
  5. 5
    Megan A. Hatlen, Lan Wang, Stephen D. Nimer, AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches, Frontiers of Medicine, 2012, 6, 3, 248

    CrossRef

  6. 6
    M. Lia, A. Carette, H. Tang, Q. Shen, T. Mo, G. Bhagat, R. Dalla-Favera, U. Klein, Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines, Blood, 2012, 119, 13, 2981

    CrossRef

  7. 7
    Dong-Joo Cheon, Sandra Orsulic, Mouse Models of Cancer, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 95

    CrossRef

  8. 8
    R. Oh-McGinnis, M. J. Jones, L. Lefebvre, Applications of the site-specific recombinase Cre to the study of genomic imprinting, Briefings in Functional Genomics, 2010, 9, 4, 281

    CrossRef

  9. 9
    Jessica C. Walrath, Jessica J. Hawes, Terry Van Dyke, Karlyne M. Reilly, 2010,

    CrossRef

  10. 10
    L. Roudaia, M. D. Cheney, E. Manuylova, W. Chen, M. Morrow, S. Park, C.-T. Lee, P. Kaur, O. Williams, J. H. Bushweller, N. A. Speck, CBF  is critical for AML1-ETO and TEL-AML1 activity, Blood, 2009, 113, 13, 3070

    CrossRef

  11. 11
    Frank Buchholz, Engineering DNA processing enzymes for the postgenomic era, Current Opinion in Biotechnology, 2009, 20, 4, 383

    CrossRef

  12. 12
    Isabelle Rubera, Edith Hummler, Friedrich Beermann, Transgenic mice and their impact on kidney research, Pflügers Archiv - European Journal of Physiology, 2009, 458, 1, 211

    CrossRef

  13. 13
    A M S Müller, J Duque, J A Shizuru, M Lübbert, Complementing mutations in core binding factor leukemias: from mouse models to clinical applications, Oncogene, 2008, 27, 44, 5759

    CrossRef

  14. 14
    E McCormack, O Bruserud, B T Gjertsen, Review: genetic models of acute myeloid leukaemia, Oncogene, 2008, 27, 27, 3765

    CrossRef

  15. 15
    Guang-biao ZHOU, Guo LI, Sai-juan CHEN, Zhu CHEN, From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era, Acta Pharmacologica Sinica, 2007, 28, 9
  16. 16
    Nadine Dragin, Shigeyuki Uno, Bin Wang, Timothy P. Dalton, Daniel W. Nebert, Generation of ‘humanized’ hCYP1A1_1A2_Cyp1a1/1a2(−/−) mouse line, Biochemical and Biophysical Research Communications, 2007, 359, 3, 635

    CrossRef

  17. 17
    Wei-yi Liu, Yun Wang, Yao Qin, Ya-ping Wang, Zuo-yan Zhu, Site-Directed Gene Integration in Transgenic Zebrafish Mediated by Cre Recombinase Using a Combination of Mutant Lox Sites, Marine Biotechnology, 2007, 9, 4, 420

    CrossRef

  18. 18
    C. Carriere, E. S. Seeley, T. Goetze, D. S. Longnecker, M. Korc, The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia, Proceedings of the National Academy of Sciences, 2007, 104, 11, 4437

    CrossRef

  19. 19
    G Putz, A Rosner, I Nuesslein, N Schmitz, F Buchholz, AML1 deletion in adult mice causes splenomegaly and lymphomas, Oncogene, 2006, 25, 6, 929

    CrossRef

  20. 20
    Louise van der Weyden, Allan Bradley, Mouse Chromosome Engineering for Modeling Human Disease, Annual Review of Genomics and Human Genetics, 2006, 7, 1, 247

    CrossRef

  21. 21
    Nicole C. Dubois, Denise Hofmann, Kostas Kaloulis, J.M. Bishop, Andreas Trumpp, Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues, genesis, 2006, 44, 8
  22. 22
    Y.-Y. Wang, G.-B. Zhou, T. Yin, B. Chen, J.-Y. Shi, W.-X. Liang, X.-L. Jin, J.-H. You, G. Yang, Z.-X. Shen, J. Chen, S.-M. Xiong, G.-Q. Chen, F. Xu, Y.-W. Liu, Z. Chen, S.-J. Chen, AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec, Proceedings of the National Academy of Sciences, 2005, 102, 4, 1104

    CrossRef

  23. 23
    E Mc Cormack, Ø Bruserud, B T Gjertsen, Animal models of acute myelogenous leukaemia – development, application and future perspectives, Leukemia, 2005, 19, 5, 687

    CrossRef

  24. 24
    Lesley F Drynan, Richard Pannell, Alan Forster, Nicole MM Chan, Florencia Cano, Angelika Daser, Terence H Rabbitts, Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis, The EMBO Journal, 2005, 24, 17
  25. 25
    Rosalind Codrington, Richard Pannell, Alan Forster, Lesley F. Drynan, Angelika Daser, Nati Lobato, Markus Metzler, Terence H. Rabbitts, The Ews-ERG Fusion Protein Can Initiate Neoplasia from Lineage-Committed Haematopoietic Cells, PLoS Biology, 2005, 3, 8, e242

    CrossRef

  26. 26
    Alan Forster, Richard Pannell, Lesley F Drynan, Rosalind Codrington, Angelika Daser, Markus Metzler, M Natividad Lobato, Terence H Rabbitts, The invertor knock-in conditional chromosomal translocation mimic, Nature Methods, 2005, 2, 1, 27

    CrossRef

  27. 27
    Björn Steffen, Carsten Müller-Tidow, Joachim Schwäble, Wolfgang E. Berdel, Hubert Serve, The molecular pathogenesis of acute myeloid leukemia, Critical Reviews in Oncology/Hematology, 2005, 56, 2, 195

    CrossRef

  28. 28
    Sylvie Giuriato, Karen Rabin, Alice C Fan, Catherine M Shachaf, Dean W Felsher, Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer, Seminars in Cancer Biology, 2004, 14, 1, 3

    CrossRef

  29. 29
    G.L Hirst, A Balmain, Forty years of cancer modelling in the mouse, European Journal of Cancer, 2004, 40, 13, 1974

    CrossRef

  30. 30
    Arndt Borkhardt, Olaf Heidenreich, RNA interference as a potential tool in the treatment of leukaemia, Expert Opinion on Biological Therapy, 2004, 4, 12, 1921

    CrossRef

  31. 31
    T. S. Fenske, G. Pengue, V. Mathews, P. T. Hanson, S. E. Hamm, N. Riaz, T. A. Graubert, Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice, Proceedings of the National Academy of Sciences, 2004, 101, 42, 15184

    CrossRef

  32. 32
    O. Heidenreich, J. Krauter, H. Riehle, P. Hadwiger, M. John, G. Heil, H.-P. Vornlocher, A. Nordheim, AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells, Blood, 2003, 101, 8, 3157

    CrossRef

  33. 33
    J. L. Grisolano, J. O'Neal, J. Cain, M. H. Tomasson, An activated receptor tyrosine kinase, TEL/PDGF R, cooperates with AML1/ETO to induce acute myeloid leukemia in mice, Proceedings of the National Academy of Sciences, 2003, 100, 16, 9506

    CrossRef

  34. 34
    Siegfried Janz, Michael Potter, Charles S. Rabkin, Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals, Genes, Chromosomes and Cancer, 2003, 36, 3
  35. 35
    James R Downing, The core-binding factor leukemias: lessons learned from murine models, Current Opinion in Genetics & Development, 2003, 13, 1, 48

    CrossRef

  36. 36
    Masakazu Higuchi, Darin O'Brien, Parasakthy Kumaravelu, Noel Lenny, Eng-Juh Yeoh, James R. Downing, Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia, Cancer Cell, 2002, 1, 1, 63

    CrossRef

  37. 37
    Chris Albanese, James Hulit, Toshiyuki Sakamaki, Richard G Pestell, Recent advances in inducible expression in transgenic mice, Seminars in Cell & Developmental Biology, 2002, 13, 2, 129

    CrossRef

  38. 38
    Maria Carmo-Fonseca, The Contribution of Nuclear Compartmentalization to Gene Regulation, Cell, 2002, 108, 4, 513

    CrossRef

  39. 39
    François Tronche, Emilio Casanova, Marc Turiault, Iman Sahly, Christoph Kellendonk, When reverse genetics meets physiology: the use of site-specific recombinases in mice, FEBS Letters, 2002, 529, 1, 116

    CrossRef

  40. 40
    Dong-Er Zhang, Encyclopedia of Cancer, 2002,

    CrossRef

  41. 41
    Y. Yuan, L. Zhou, T. Miyamoto, H. Iwasaki, N. Harakawa, C. J. Hetherington, S. A. Burel, E. Lagasse, I. L. Weissman, K. Akashi, D.-E. Zhang, AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations, Proceedings of the National Academy of Sciences, 2001, 98, 18, 10398

    CrossRef

  42. 42
    T.H. Rabbitts, A. Appert, G. Chung, E.C. Collins, L. Drynan, A. Forster, M.N. Lobato, M.P. McCormack, R. Pannell, A. Spandidos, M.R. Stocks, T. Tanaka, E. Tse, Mouse Models of Human Chromosomal Translocations and Approaches to Cancer Therapy, Blood Cells, Molecules, and Diseases, 2001, 27, 1, 249

    CrossRef

  43. 43
    Thomas Boehm, A new era of cancer research: Cutting and pasting of chromosomes, International Journal of Cancer, 2000, 88, 2
  44. 44
    Giuseppe Testa, A Francis Stewart, Creating a transloxation, EMBO reports, 2000, 1, 2
  45. 45
    Silvia Grisendi, Pier Paolo Pandolfi, Germline Modification Strategies, Mouse Models of Human Cancer,